Drugs / Spray-dried S/D-treated Plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01589666 | Nov 2013 → Sep 2016 | blood coagulation disease | Entegrion, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Spray-dried S/D-treated Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01589666 ↗ |
| Known as | Resusix | “5 doses of spray-dried solvent/detergent treated plasma (Resusix®) in healthy volunteers.” NCT01589666 ↗ |